RE:Lets try & stay on topic, this is a great and detailed reporCanadafan invests his hard earned savings in a stock and then honestly believes that the SP is not significant. One can only imagine the amount he has lost on his investment in ONC (and other companies) with this mindset over the past couple of decades.
Not once in the past 24 years has an analyst (or Canadafan) correctly predicted an uptick in ONC's shareprice.
ONC's shares are in the toilet right now for many reasons, some of the top that come to mind are:
1. Pelareorep (aka Reolysin) has failed every phase 2 trial ever conducted, regardless of the combination therapy employed.
2. Pelareorep has not advanced to a Phase 3 BC trial now FIVE YEARS after concluding its heralded P2 and announcing itself as a "Breast Cancer Company"
3. 120 days and counting since MC's self-imposed 90 day period for formalizing PanCAN.
4. ATM ATM ATM ATM ATM (gotta pay those salaries!!)
5. MATT COFFEY is the CEO
And...
Can't fix #1, unless they change the product name again and sweep everything under the carpet.
Can't fix #2... the BC file is never going forward.
Can't fix #3... MC has zero credibility, always overpromises and underdelivers.
Can't fix #4... ONC is as addicted to their ATM as any penny stock biotech.
Can Fix #5... Step up B.O.D!
Very sad to think that after 25 years it is one small Panc trial with about a dozen patients enrolled that is keeping this whole stinking ship afloat.
Oh, but do keep on posting Canadafan. Always entertaining, thanks.